Sinopia Biosciences
Sinopia Biosciences is transforming the way disease research and drug discovery are conducted. While target-based drug discovery has been the primary method for the past thirty years, the complexity and unknown causes of many diseases have led to a shift towards phenotypic screening. This approach, which focuses on a limited number of specific indicators, has proven to be more effective in finding groundbreaking medications. Sinopia is utilizing advanced techniques such as high-throughput multi-omics data analysis, machine learning, and disease models to make data-driven drug discovery a reality.
Sinopia Biosciences is transforming the way disease research and drug discovery are conducted. While target-based drug discovery has been the primary method for the past thirty years, the complexity and unknown causes of many diseases have led to a shift towards phenotypic screening. This approach, which focuses on a limited number of specific indicators, has proven to be more effective in finding groundbreaking medications. Sinopia is utilizing advanced techniques such as high-throughput multi-omics data analysis, machine learning, and disease models to make data-driven drug discovery a reality.
Sinopia Biosciences has raised $2.2M across 3 rounds. Its most recent round was a Series Unknown of $2.2M in Sep 2024. Full funding history, investors, and team are detailed below.
Funding history
3 rounds on record — latest round shown, the rest unlock with a paid plan.
Unlock 2 earlier rounds — dates, amounts, round types — plus the lead investor for every round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Sinopia Biosciences is featured in
Similar companies
Verisoul is a company that designs a decentralized platform with artificial intelligence, aiming to aid businesses in combating the presence of fraudulent users. By merging anonymity and accountability, Verisoul collaborates with Web3 developers to enable them in identifying reliable users while distinguishing them from scammers, bots, and imposters.
Model ML is an AI tool that improves workflows for investment banks and private equity firms by integrating multiple data sources for research and due diligence, with the goal of revolutionizing the finance industry with a more efficient AI workspace.
Apptronik fabricates and plans human-focused mechanical technology frameworks.
Momentic allows developers to deploy AI agents to test the complete functionality of web applications by simply describing user flows in a natural language.
The company Harmonic creates Mathematical Superintelligence (MSI), a cutting-edge artificial intelligence system grounded in mathematical principles to ensure precision and eliminate errors.
Scale Social is an AI-powered marketing platform that automates capturing, curating, and distributing customer-generated content. It is specifically designed to help small businesses drive growth through authentic, high-impact digital marketing.
Federato's RiskOps underwriting platform for insurance carriers, MGAs and MGUs provides real-time risk selection and portfolio insights to empower underwriters to balance their book of business and make better underwriting decisions.
Kalshi is a financial exchange that is regulated by the government and allows investors to trade based on their predictions of future events. The markets offered by Kalshi cover various topics such as economics, international affairs, media, entertainment, climate, and public health. Unlike traditional instruments like stocks or bonds, Kalshi's markets are more specific, giving investors direct exposure to events and trends they are interested in. For example, a market on the signing of a free trade agreement can help retail investors gain exposure to emerging markets and changes in international trade. Check out their website at https://kalshi.com.
Suno is a music startup that allows individuals to create the music they desire, with the goal of helping people find pleasure in play and discovery once again.
Organizations trust Numeric to guarantee the accuracy of their financial information, streamline the month-end closing process, and provide immediate insights. With a rating of 4.9 out of 5 on G2.
AI Proteins is a biotechnology company that focuses on the design and engineering of synthetic mini protein therapeutics. The company was founded in 2021 and is headquartered in Boston, Massachusetts.
Luma is an AI company building the future of 3D.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.